Details for Patent: 12,419,833
Which drugs does patent 12,419,833 protect, and when does it expire?
Patent 12,419,833 protects XIPERE and is included in one NDA.
This patent has seven patent family members in six countries.
Summary for Patent: 12,419,833
| Title: | Injectable triamcinolone formulations |
| Abstract: | The present disclosure relates to pharmaceutical suspensions of triamcinolone acetonide, methods of producing such suspensions and methods of using of such suspensions. The pharmaceutical suspensions of the present disclosure are stable and suitable for administration by suprachoroidal injection through a 30-gauge microneedle. |
| Inventor(s): | Thai Q Nguyen, Brian Burke, Edward Lee, Rafael Victor Andino |
| Assignee: | Clearside Biomedical Inc |
| Application Number: | US17/603,816 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 12,419,833
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | XIPERE | triamcinolone acetonide | SUSPENSION;INJECTION | 211950-001 | Oct 22, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | TREATMENT OF MACULAR EDEMA ASSOCIATED WITH UVEITIS | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,419,833
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 3136814 | ⤷ Start Trial | |||
| China | 114206348 | ⤷ Start Trial | |||
| European Patent Office | 3955934 | ⤷ Start Trial | |||
| South Korea | 20220019667 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
